The Pro Trump News homepage features 60 fresh headlines every day. Click here to view.
The Swiss pharmaceutical leader Roche plans to invest billions in the US over the next five years.
The Swiss pharmaceutical leader Roche stated on Tuesday that it intends to invest over $50 billion in the US in the coming five years.
The US represents a crucial market for the pharmaceutical sector, generating more than half of Roche’s pharmaceutical sector revenues, as reported by AFP.
“These investments are projected to enhance Roche’s already substantial presence in the US with 13 manufacturing and 15 R&D facilities in both the pharmaceutical and diagnostics sectors, which will create over 12,000 new positions, including nearly 6,500 in construction and 1,000 in new or expanded sites,” Roche stated.
According to their press release:
Enhanced and modernized US manufacturing and distribution capabilities for innovative pharmaceuticals and diagnostic offerings in Kentucky, Indiana, New Jersey, Oregon, and California
A state-of-the-art gene therapy facility in Pennsylvania
A new 900,000-square-foot manufacturing center to support Roche’s growing portfolio of next-generation weight loss treatments (location to be announced)
New manufacturing facility for ongoing glucose monitoring in Indiana
A new R&D center in Massachusetts focusing on advanced artificial intelligence (AI) research, serving as a hub for new cardiovascular, kidney, and metabolism R&D activities
Major expansion and improvement of existing drug and diagnostic R&D facilities in Arizona, Indiana, and California
Another win for Trump!
advertisement
